{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:06:26Z","timestamp":1772118386138,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T00:00:00Z","timestamp":1364515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Antiepileptic drugs (<jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s) do not effectively treat 30\u201340% of patients with epilepsy. Export of <jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s by <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\u2010glycoprotein (<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>gp, <jats:styled-content style=\"fixed-case\"><jats:italic>ABCB1<\/jats:italic><\/jats:styled-content>, or <jats:styled-content style=\"fixed-case\"><jats:italic>MDR1<\/jats:italic><\/jats:styled-content>), which is overexpressed in the blood\u2013brain barrier in drug\u2010resistant patients, may be a mechanism for resistance to <jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s. For most recently approved <jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s, whether they are transported by <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>gp is unknown. We investigated whether a new <jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>, lacosamide (<jats:styled-content style=\"fixed-case\">LCM<\/jats:styled-content>), is a substrate of human <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>gp.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">LLC<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PK<\/jats:styled-content>1 and <jats:styled-content style=\"fixed-case\">MDCKII<\/jats:styled-content> cells transfected with the human <jats:italic><jats:styled-content style=\"fixed-case\">MDR<\/jats:styled-content>1<\/jats:italic> gene were used to determine the substrate status of <jats:styled-content style=\"fixed-case\">LCM<\/jats:styled-content> in concentration equilibrium transport assays (<jats:styled-content style=\"fixed-case\">CETAs<\/jats:styled-content>). An equal concentration of drug was initially loaded in both the apical and basal chambers, and the concentration in both chambers was measured up to 4\u00a0h. The experiments were repeated in the presence of the <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>gp inhibitors verapamil and tariquidar. Caco\u20102 assays were used to determine the intrinsic permeability and efflux ratio of <jats:styled-content style=\"fixed-case\">LCM<\/jats:styled-content> as well as its potential to inhibit digoxin, a <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>gp substrate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Findings<\/jats:title><jats:p>Lacosamide was transported by <jats:styled-content style=\"fixed-case\"><jats:italic>MDR1<\/jats:italic><\/jats:styled-content>\u2010transfected cells from basolateral to apical sides. The efflux of <jats:styled-content style=\"fixed-case\">LCM<\/jats:styled-content> could be completely blocked by verapamil or tariquidar. In <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>aco\u20102 assays, <jats:styled-content style=\"fixed-case\">LCM<\/jats:styled-content> showed high permeability without a significant efflux ratio; it did not inhibit digoxin, a <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>gp substrate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Significance<\/jats:title><jats:p>Although <jats:styled-content style=\"fixed-case\">LCM<\/jats:styled-content> is a substrate of <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>gp in <jats:styled-content style=\"fixed-case\">CETA<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> C<\/jats:styled-content>aco\u20102 data demonstrated that passive diffusion should play a major role in the overall disposition of <jats:styled-content style=\"fixed-case\">LCM<\/jats:styled-content>. The critical role of <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>gp should be addressed in vivo.<\/jats:p><\/jats:sec>","DOI":"10.1111\/epi.12158","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T12:49:37Z","timestamp":1364561377000},"page":"1154-1160","source":"Crossref","is-referenced-by-count":26,"title":["Potential role for human P\u2010glycoprotein in the transport of lacosamide"],"prefix":"10.1111","volume":"54","author":[{"given":"Chunbo","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Pharmacy The Chinese University of Hong Kong Hong Kong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugues","family":"Chanteux","sequence":"additional","affiliation":[{"name":"UCB Pharma Braine\u2010l'Alleud Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Zuo","sequence":"additional","affiliation":[{"name":"School of Pharmacy The Chinese University of Hong Kong Hong Kong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[{"name":"Division of Neurology Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China"},{"name":"Departments of Medicine and Neurology The University of Melbourne Royal Melbourne Hospital Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Baum","sequence":"additional","affiliation":[{"name":"School of Pharmacy The Chinese University of Hong Kong Hong Kong China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00128-9"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.102491"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.07.038"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(00)00141-X"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969040-00005"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.12301.x"},{"key":"e_1_2_7_8_1","first-page":"64","volume-title":"Guidance for industry: drug interaction studies \u2013 study design, data analysis, implications for dosing, and labeling recommendations","author":"Food and Drug Administration","year":"2012"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135308"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2005.31904.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004418"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1728"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.08.032"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-9961-8"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp800122b"},{"issue":"4","key":"e_1_2_7_16_1","first-page":"2","article-title":"Lacosamide has low potential for drug\u2010drug interaction","volume":"50","author":"Thomas D","year":"2009","journal-title":"Epilepsia"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb01657.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.1.2.175"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.12.024"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.054197"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-005-5303-7"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.04.008"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03140.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2011.12.003"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fepi.12158","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.12158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T02:05:10Z","timestamp":1696298710000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.12158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,29]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1111\/epi.12158"],"URL":"https:\/\/doi.org\/10.1111\/epi.12158","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,29]]}}}